This study aimed to evaluate changes in sleep during the COVID-19 outbreak, and used data-driven approaches to identify distinct profiles of changes in sleep-related behaviors. Demographic, behavioral and psychological factors associated with sleep changes were also investigated.
Cognitive behavioral therapy is the first line treatment for insomnia, but studies have reported potential negative effects. This review aims to understand the extent to which adverse events are monitored for and reported in trial literature.
Patients with fibromyalgia suffer from chronic pain, which limits physical activity and is associated with disturbed sleep. However, the relationship between physical activity, pain, and sleep is unclear.
This study addresses possible consequences of the COVID-19 crisis and home confinement on maternal anxiety, maternal insomnia, and maternal reports of sleep problems among children aged 6–72 months.
In order to assess the efficacy and safety of JZP-258, a lower sodium alternative product to sodium oxybate, study authors designed a double-blind, placebo-controlled, randomized withdrawal, multicenter study with an open-label safety extension.
The list, titled “Five Things Physicians and Patients Should Question,” was developed by members of the AAP Section on Pediatric Pulmonology and Sleep Medicine.
The use of intensive lifestyle intervention for weight loss in patients with type 2 diabetes has been shown to reduce the overall severity of obstructive sleep apnea.
